Cognition Therapeutics, Inc. (CGTX) Tops Q1 EPS by 2c

Cognition Therapeutics, Inc. (NASDAQ: CGTX) reported Q1 EPS of ($0.05), $0.02 better than the analyst estimate of ($0.07).

For earnings history and earnings-related data on Cognition Therapeutics, Inc. (CGTX) click here.

You May Also Be Interested In

• Grandstand Limited (GRSD) Tops Q2 EPS by 5c; Offers Guidance
• Virtra Systems, Inc. (VTSI) Tops Q2 EPS by 9c
• TMC the metals company Inc. (TMC) Misses Q2 EPS by 8c